Ces radiol. 2020, 74(1):28-32 | DOI: 10.55095/CesRadiol2020/005

Calcifications in adrenal masses - are they really typical for adrenocortical carcinomas?Original article

Filip Čtvrtlík1, Petr Kučera1, Zuzana Sedláčková1, Kateřina Langová2, Igor Hartmann3, Milan Král3, Jozef Škarda4, Jan Baxa5, Milan Hora6, Zbyněk Tüdös1
1 Radiologická klinika, Lékařská fakulta Univerzity Palackého v Olomouci a Fakultní nemocnice Olomouc
2 Ústav lékařské biofyziky, Lékařská fakulta Univerzity Palackého v Olomouci, Olomouc
3 Urologická klinika, Lékařská fakulta Univerzity Palackého v Olomouci a Fakultní nemocnice Olomouc
4 Ustav klinické a molekulární patologie, Lékařská fakulta Univerzity Palackého v Olomouci a Fakultní nemocnice Olomouc
5 Klinika zobrazovacích metod, Fakultní nemocnice Plzeň a Lékařské fakulta Univerzity Karlovy v Plzni
6 Urologická klinika, Fakultní nemocnice Plzeň a Lékařské fakulta Univerzity Karlovy v Plzni

Aim: The aim of the study was to assess the truth of the statement that the presence of calcifications in imaging methods is typical of adrenocortical carcinomas and to verify how often they are present in various types of expansions.

Methodology: This retrospective study conducted at the University Hospitals in Olomouc and Pilsen was conducted in 2003-2019 and includes patients with adrenal tumours who underwent adrenalectomy, followed by histological diagnosis of expansion. The final group included the following diagnoses: adenoma, pheochromocytoma, adrenocortical carcinoma, metastasis, and myelolipoma. The sample includes 268 patients (138 men and 130 women). We evaluated the age and sex of the patients and the presence of calcifications in individual diagnoses.

Results: Calcifications were least frequent in patients with metastases (only in 5% of cases); on the contrary, they were most common in myelolipomas (38%). In adrenocortical carcinomas they occurred only in 20% of the patients.

Conclusion: Calcifications are not a typical finding in adrenocortical carcinomas. They were significantly more frequent in myelolipomas than in other histological groups.

Keywords: adenoma, adrenocortical carcinoma, pheochromocytoma, metastases, computed tomography, calcification
Grants and funding:

Podpořeno z programového projektu Ministerstva zdravotnictví ČR s reg. č. 17-31847A.

Accepted: January 30, 2020; Published: March 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čtvrtlík F, Kučera P, Sedláčková Z, Langová K, Hartmann I, Král M, et al.. Calcifications in adrenal masses - are they really typical for adrenocortical carcinomas? Ces radiol. 2020;74(1):28-32. doi: 10.55095/CesRadiol2020/005.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wang S, Chen S-S, Gao W-C, et al. Prognostic factors of adrenocortical carcinoma: An Analysis of the Surveillance Epidemiology and End Results (SEER) Database. Asian Pac J Cancer Prev 2017; 18(10): 2817-2823.
    2. Fassnacht M, Dekkers OM, Else T, et al. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology 2018; 179(4): G1-G46. Go to original source... Go to PubMed...
    3. Kostiainen I, Hakaste L, Kejo P, et al. Adrenocortical carcinoma: presentation and outcome of a contemporary patient series. Endocrine 2019; 65(1): 166-174. Go to original source... Go to PubMed...
    4. Čtvrtlík F, Heřman M, Študent V, Tichá V, Minařík J. Differential diagnosis of incidentally detected adrenal masses revealed on routine abdominal CT. European Journal of Radiology 2009; 69(2): 243-252. Go to original source... Go to PubMed...
    5. Ctvrtlik F, Koranda P, Tichy T. Adrenal disease: A clinical update and overview of imaging. A review. Biomedical Papers 2014; 158(1): 23-34. Go to original source... Go to PubMed...
    6. Ctvrtlik F, Tudos Z, Szasz P, et al. Characteristic CT features of pheochromocytomas - probability model calculation tool based on a multicentric study. Biomedical Papers 2019; 163(3): 212-219. Go to original source... Go to PubMed...
    7. Dunnick NR, Heaston D, Halvorsen R, Moore AV, Korobkin M. CT Appearance of Adrenal Cortical Carcinoma. Journal of Computer Assisted Tomography 1982; 6(5): 978. Go to original source... Go to PubMed...
    8. Kandathil A, Wong KK, Wale DJ, et al. Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature. Endocrine 2015; 49(1): 6-26. Go to original source... Go to PubMed...
    9. Thomas AJ, Habra MA, Bhosale PR, et al. Interobserver agreement in distinguishing large adrenal adenomas and adrenocortical carcinomas on computed tomography. Abdom Radiol (NY) 2018; 43(11): 3101-3108. Go to original source... Go to PubMed...
    10. Zini L, Porpiglia F, Fassnacht M. Contemporary Management of Adrenocortical Carcinoma. European Urology 2011; 60(5): 1055-1065. Go to original source... Go to PubMed...
    11. Wein A, Kavoussi L, Partin A, Peters C. Campbell-Walsh Urology, 11th Edition. Elsevier; https://www.elsevier.ca/ca/product.jsp?isbn=9781455775675. Accessed July 1, 2019.
    12. Fishman EK, Deutch BM, Hartman DS, Goldman SM, Zerhouni EA, Siegelman SS. Primary adrenocortical carcinoma: CT evaluation with clinical correlation. AJR Am J Roentgenol 1987; 148(3): 531-535. Go to original source... Go to PubMed...
    13. Ribeiro RC, Michalkiewicz EL, Figueiredo BC, et al. Adrenocortical tumors in children. Braz J Med Biol Res 2000; 33(10): 1225-1234. Go to original source... Go to PubMed...
    14. Rockall AG, Babar SA, Sohaib SAA, et al. CT and MR Imaging of the Adrenal Glands in ACTH-independent Cushing Syndrome. RadioGraphics 2004; 24(2): 435-452. Go to original source... Go to PubMed...
    15. Zhang HM, Perrier ND, Grubbs EG, et al. CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies. Clin Radiol 2012; 67(1): 38-46. Go to original source... Go to PubMed...
    16. Dunnick NR. Adrenal carcinoma. Radiol Clin North Am 1994; 32(1): 99-108. Go to original source...
    17. Bharwani N, Rockall AG, Sahdev A, et al. Adrenocortical carcinoma: The range of appearances on CT and MRI. American Journal of Roentgenology 2011; 196(6): W706-W714. Go to original source... Go to PubMed...
    18. Petersenn S, Richter P-A, Broemel T, et al. Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas: analysis of the German ACC registry. Eur J Endocrinol 2015; 172(4): 415-422. Go to original source... Go to PubMed...
    19. Ilias I, Sahdev A, Reznek RH, Grossman AB, Pacak K. The optimal imaging of adrenal tumours: a comparison of different methods. Endocrine-Related Cancer 2007; 14(3): 587-599. Go to original source... Go to PubMed...
    20. Park BK, Kim CK, Kwon GY, Kim JH. Re-evaluation of pheochromocytomas on delayed contrast-enhanced CT: washout enhancement and other imaging features. Eur Radiol 2007; 17(11): 2804-2809. Go to original source... Go to PubMed...
    21. Kenney PJ, Stanley RJ. Calcified adrenal masses. Urol Radiol 1988; 9(1): 9-15. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content